throbber
Trials@uspto.gov
`Tel: 571-272-7822
`
`
`Paper 35
`Entered: August 23, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`QUALICAPS CO., LTD.,
`Patent Owner.
`
`Case IPR2017-00203
`Patent 6,649,180 B1
`
`Before BRIAN P. MURPHY, CHRISTOPHER M. KAISER, and JEFFREY
`W. ABRAHAM, Administrative Patent Judges.
`
`MURPHY, Administrative Patent Judge.
`
`DECISION
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`
`I.
`
`INTRODUCTION
`
`On August 3, 2017, Mylan Pharmaceuticals Inc. (“Petitioner”) sent an
`email to the Board requesting a teleconference to discuss Petitioner’s request
`that Mr. Masaru Tanjoh “be presented for cross-examination as a part of
`routine discovery” or, in the alternative, that Petitioner be authorized to file a
`motion for additional discovery “in the form of Mr. Tanjoh’s deposition.”
`Ex. 2061, 2. Mr. Tanjoh is an inventor of U.S. Patent No. 6,649,180 B1, the
`patent at issue in this proceeding. Ex. 1001 (“the ’180 patent”). Qualicaps
`Co., Ltd. (“Patent Owner”) relies on the Declaration testimony of Mr.
`Tanjoh, submitted during prosecution of the ’180 patent (Ex. 1010, 105–
`108), as evidence of unexpected results in its Response to the Petition.
`Paper 26 (“PO Resp.”), 29, 33–35.
`Petitioner’s email indicated that Patent Owner had refused to make
`Mr. Tanjoh available for cross-examination. Ex. 2061, 1. The Board
`responded by email on August 3, 2017encouraging the parties to reach
`agreement regarding Mr. Tanjoh’s cross-examination, and authorizing
`Petitioner to file a motion for additional discovery in the absence of such
`agreement. Ex. 2061, 1.
`On August 11, 2017, Petitioner filed a Motion for Additional
`Discovery pursuant to 37 C.F.R. § 42.51(b)(2). Paper 31 (“Motion” or
`“Mot.”). Petitioner’s motion requests:
`(i) Mr. Tanjoh’s deposition, and
`“[A]ll documents in Patent Owner and/or Mr. Tanjoh’s
`(ii)
`possession, custody, or control, supporting or refuting Patent
`Owner’s assertion that the invention of the U.S. Patent
`
`
`
`2
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`6,649,180 (“the ‘180 patent”) yielded unexpected results,” or,
`in the alternative,
`(iii) That Patent Owner produce “the entirety” of Mr. Tanjoh’s
`March 17, 2017 30(b)(6) deposition transcript from the co-
`pending litigation between the parties “with exhibits including
`any portion or document marked confidential.”
`Id., 1. Petitioner notes that Patent Owner declined to produce Mr. Tanjoh
`for a deposition in the present proceeding, and instead offered to consent to
`the use of Mr. Tanjoh’s March 17, 2017 deposition transcript from the
`litigation in the present proceeding. Mot., 2 (citing Ex. 1022). The parties’
`dispute centers on Petitioner’s document request and Patent Owner’s refusal
`to agree to produce certain deposition exhibits designated as “Restricted–
`Attorneys’ Eyes Only” as part of its consent to the use of Mr. Tanjoh’s
`March 17th deposition transcript. Ex. 1023, 1–2.
`Patent Owner justifies its refusal to provide Mr. Tanjoh for deposition
`because it has offered to file the complete deposition “testimony” of his
`March 17th deposition, which includes testimony regarding the issue of
`unexpected results. Paper 32, 4 (“Opposition” or “Opp.”). Patent Owner
`further states that Mr. Tanjoh is approximately 70 years old, resides in
`Japan, and requires an interpreter for deposition. Id. at 7. Patent Owner
`stresses that Mr. Tanjoh is a fact witness, his Declaration does not contain
`expert opinion testimony, and Patent Owner’s expert, Dr. McConville,
`provided expert opinion testimony regarding unexpected results and was
`cross-examined by Petitioner on August 17, 2017. Id. at 3, 5–7. Patent
`Owner asserts that Petitioner’s document request and request for a “second”
`deposition of Mr. Tanjoh are unduly burdensome, particularly because
`Petitioner has not alleged the confidential deposition exhibits being
`3
`
`
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`requested are directed to the experiments, data, and statements made in Mr.
`Tanjoh’s Declaration, as opposed to the other 30(b)(6) deposition topics for
`which Mr. Tanjoh was designated as Patent Owner’s corporate
`spokesperson. Id. at 4, 6–7.
`
`
`II. ANALYSIS
`
`
`A. Requested Deposition of Mr. Tanjoh
`Patent Owner bears the burden of producing objective evidence of
`nonobviousness in rebuttal to Petitioner’s evidence of obviousness.1
`Prometheus Labs., Inc. v. Roxane Labs., Inc., 805 F.3d 1092, 1101-02 (Fed.
`Cir. 2015). Patent Owner affirmatively relies on Mr. Tanjoh’s Declaration
`testimony in support of its burden of production, and Dr. McConville relies
`on Mr. Tanjoh’s Declaration as a basis for his opinion of unexpected results.
`PO Resp. 29, 33–35 (citing Ex. 1010, 106–107; Ex. 2028 ¶¶ 99–100).
`Although Patent Owner sets out very practical reasons for why Mr. Tanjoh’s
`deposition in this proceeding may be inconvenient and unnecessary, Patent
`Owner does not state that Mr. Tanjoh is unavailable for deposition. Opp. 6–
`7. Given that Dr. McConville relies directly on the experiments and data
`provided in Mr. Tanjoh’s Declaration for Dr. McConville’s opinion of
`unexpected results (Ex. 2028 ¶¶ 99–100), we are satisfied Petitioner has
`established the utility of the requested deposition testimony as it relates to
`Mr. Tanjoh’s Declaration and that a deposition would not be unduly
`burdensome. See Garmin Int’l Inc. et al. v. Cuozzo Speed Techs. LLC, Case
`
`
`1 To be clear, Petitioner bears the ultimate burden of persuasion regarding
`the asserted obviousness of the challenged claims.
`4
`
`
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`IPR2012-00001, Paper 26 (PTAB March 5, 2013) (Garmin factors 1 and 5).
`Petitioner is entitled to cross-examine Mr. Tanjoh with regard to the
`experiments, data, and statements in Mr. Tanjoh’s Declaration, particularly
`regarding the criticality of the boundaries for combined methoxyl group and
`hydroxypropoxyl group content. Mot. 4.
` With regard to Garmin factor 3, availability of equivalent
`information by other means, Petitioner acknowledges that the March 17th
`deposition of Mr. Tanjoh addresses Mr. Tanjoh’s Declaration and the issue
`of unexpected results, one of the enumerated topics for which Mr. Tanjoh
`was designated to testify as Patent Owner’s representative. Mot. 4–5
`(“Patent Owner designated Mr. Tanjoh . . . to testify on this [secondary
`considerations including unexpected results] topic”), 6–7; Ex. 1024, 6
`(Topic 17).2 Petitioner expressly acknowledges that the issue of
`“unexpected results via the inventor’s declaration . . . is addressed in the
`deposition transcript and exhibits thereto,” and that “the foundation, context,
`and facts underlying Mr. Tanjoh’s Declaration easily could be made
`available in these proceedings via deposition or production of Mr. Tanjoh’s
`deposition from the district court litigation.” Mot. 6. Patent Owner has
`consented to filing Mr. Tanjoh’s “complete testimony” from his March 17th
`district court deposition in this proceeding, with due accommodation for
`
`
`2 Regarding Garmin factor 2 – whether Petitioner seeks Patent Owner’s
`litigation positions and the underlying bases therefore – we are not
`persuaded that Petitioner’s request seeks Patent Owner’s litigation positions.
`Opp. 5. The parties have exchanged expert reports and completed expert
`discovery in the district court litigation. Mot. 5. Likewise, Petitioner’s
`requests are easily understandable (Garmin factor 4). Given the
`circumstances of Petitioner’s Motion, however, these two factors are not
`determinative of the result.
`
`
`
`5
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`entry of a protective order and a motion to seal. Opp. 6–7; Ex. 1023, 4.
`Therefore, both parties agree that the requested deposition testimony is
`available to Petitioner from the district court litigation.
`We now turn to the disputed scope of Petitioner’s document request.
`B. The Requested Documents
`Petitioner requests “all documents” supporting or refuting Patent
`Owner’s assertion of unexpected results, including all exhibits from Mr.
`Tanjoh’s March 17th deposition. Mot. 1, 7. Such a district court litigation
`style document request does not comply with the Board’s rule for focused,
`limited discovery, and it is unduly burdensome (Garmin factors 1 and 5). 37
`C.F.R. 42.51 (b); see Garmin, Paper 26 at 7. Petitioner implicitly recognizes
`that the relevant documents are those “documents related to [Mr. Tanjoh’s]
`experimentation” set out in his Declaration. Mot. 5. Mr. Tanjoh’s 30(b)(6)
`deposition testimony, moreover, included testimony on many topics far
`afield from the subject of unexpected results and the content of his
`Declaration at issue in this proceeding. See Ex. 1024, 9 (topic 17). Mr.
`Tanjoh was designated to testify on 17 of 30 topics requested in Petitioner’s
`30(b)(6) deposition notice of Patent Owner, including publication of related
`patent applications and articles (topic 2), first offer for sale and public use of
`the claimed invention (topic 4), validity, infringement, and prior art searches
`or investigations (topic 8), non-infringing substitutes (topic 16), and the
`“function of the hard capsule in Delzicol®” (topic 22). Compare Ex. 1024
`with Ex. 1025. Such testimony and related documents are not relevant to
`this proceeding.
` Although it is true that Petitioner did not raise the issue of deposition
`exhibits in its request for authorization to file a motion for additional
`discovery (Opp. 1), under the circumstances we find no fault with an
`6
`
`
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`appropriately limited request for documents relating to the experiments, data,
`and statements made in Mr. Tanjoh’s Declaration (Ex. 1010, 105–108).
`Such documents are relevant in this proceeding, particularly with regard to
`permitting Petitioner to test the criticality of the boundaries for combined
`methoxyl group and hydroxypropoxyl group content that are the subject of
`Mr. Tanjoh’s Declaration and Dr. McConville’s opinion testimony based
`thereon. Therefore, to the extent such documents were marked as exhibits
`during Mr. Tanjoh’s March 17th deposition, the documents should be
`produced by Patent Owner in this proceeding. Patent Owner may file the
`documents under seal in accordance with a joint request for entry of a
`protective order.
`
`
`
`
`
`7
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`
`III. ORDER
`
`
`Accordingly, it is:
`ORDERED that Petitioner’s motion for additional discovery is
`granted-in-part and denied-in-part, as follows:
`Patent Owner shall serve and file, in the present proceeding,
`the complete transcript of Mr. Tanjoh’s March 17, 2017
`deposition testimony taken by Petitioner in the district court
`proceeding; and
`Patent Owner shall serve and file, in the present proceeding, the
`documents relating to the experiments, data, and statements in
`Mr. Tanjoh’s Declaration (Ex. 1010, 105–108) that were
`marked as exhibits at Mr. Tanjoh’s March 17, 2017 deposition;
`FURTHER ORDERED that Patent Owner and Petitioner shall file a
`joint motion to seal the aforementioned deposition transcript and exhibits
`and for entry of a protective order in accordance with 37 C.F.R. § 42.54; see
`Garmin International v. Cuozzo Speed Technologies, LLC, Case IPR2012-
`00001, slip op. at 1–2 (PTAB March 14, 2013) (Paper 34) (discussing the
`standards of the Board applied to motions to seal); and
`FURTHER ORDERED that the actions ordered above shall be
`completed within one week from the date of this ORDER.
`
`
`
`
`
`
`
`
`
`
`
`8
`
`

`

`IPR2017-00203
`Patent 6,649,180 B1
`FOR PETITIONER:
`
`Mitchell Stockwell
`mstockwell@kilpatricktownsend.com
`
`Clay Holloway
`cholloway@kilpatricktownsend.com
`
`Miranda Rogers
`mrogers@kilpatricktownsend.com
`
`Jonathan D. Olinger
`jolinger@killpatricktownsend.com
`
`
`FOR PATENT OWNER:
`
`Jessica Parezo
`jparezo@cov.com
`
`Andrea Reister
`areister@cov.com
`
`Scott Kamholz
`skamholz@cov.com
`
`Michael Kennedy
`mkennedy@cov.com
`
`Megan Keane
`mkeane@cov.com
`
`Maryanne Armstrong
`maa@bskb.com
`
`Lynde Herzbach
`lynde.herzbach@bskb.com
`
`
`
`9
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket